Breaking News
IT'S OVER: Banks Tap Fed for $17 BILLION as Silver Shorts Implode
SEMI-NEWS/SEMI-SATIRE: December 28, 2025 Edition
China Will Close the Semiconductor Gap After EUV Lithography Breakthrough
The Five Big Lies of Vaccinology
Top Tech News
EngineAI T800: Born to Disrupt! #EngineAI #robotics #newtechnology #newproduct
This Silicon Anode Breakthrough Could Mark A Turning Point For EV Batteries [Update]
Travel gadget promises to dry and iron your clothes – totally hands-free
Perfect Aircrete, Kitchen Ingredients.
Futuristic pixel-raising display lets you feel what's onscreen
Cutting-Edge Facility Generates Pure Water and Hydrogen Fuel from Seawater for Mere Pennies
This tiny dev board is packed with features for ambitious makers
Scientists Discover Gel to Regrow Tooth Enamel
Vitamin C and Dandelion Root Killing Cancer Cells -- as Former CDC Director Calls for COVID-19...
Galactic Brain: US firm plans space-based data centers, power grid to challenge China
Flourescent biotechnology for high lighting solid cancer for more complete surgical removal
.... On Target Laboratories LLC is working to advance its revolutionary fluorescent imaging technology that could help surgeons pinpoint and remove more cancerous tissues than has ever been possible while preserving more healthy tissue for patients.
Headquartered at Purdue Research Park of West Lafayette, the company is developing a series of molecules, which, when administered intravenously, show promise in targeting many types of cancer cells, said Dr. Sumith Kularatne, On Target's vice president of research and development.
"In addition to our current U.S. patents, we have 11 more either filed or pending in the U.S.," Kularatne said. "We have another 33 patents pending worldwide. These patents are very important in helping us move our discoveries to the public where they can help people."